Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Dec;107(4):956–963. doi: 10.1111/j.1476-5381.1992.tb13391.x

Effects of PAF on excitatory neuro-effector transmission in dog airways.

K Tashiro 1, Z Xie 1, Y Ito 1
PMCID: PMC1907945  PMID: 1334755

Abstract

1. Effects of PAF on excitatory neuro-effector transmission in smooth muscle cells of mucosa-free trachea and epithelium-intact bronchiole of the dog were investigated, by isometric tension recording, microelectrode and double sucrose-gap methods. 2. PAF (10(-11)-10(-7) M) dose-dependently enhanced the amplitude of contraction evoked by repetitive field stimulations (10 stimuli at 20 Hz) in both tracheal and bronchiolar tissues. At higher concentrations PAF (> 10(-8) M) increased the amplitude of contraction to a greater extent in the bronchiole than in the trachea. 3. In both muscle tissues, in parallel to the amplitude of contraction, PAF markedly enhanced the amplitude of excitatory junction potentials (e.j.ps) evoked by a single field stimulation in a dose-dependent manner, with no change in the resting membrane potential or input membrane resistance of the smooth muscle cells. PAF (5 x 10(-7) M) enhanced the amplitude of e.j.p. to a greater extent in the bronchiole than in the trachealis. In contrast, lyso-PAF (10(-10)-10(-7) M) showed no effect on e.j.p. amplitude in bronchiolar tissues. At a high concentration (10(-7) M) lyso-PAF slightly enhanced the e.j.p. amplitude in tracheal tissue, however the lyso-PAF induced stimulation of e.j.p. amplitude in the trachea was small compared to that of PAF. 4. PAF (10(-7) M) had no effect on the membrane depolarization induced by acetylcholine (ACh, 10(-9)-10(-5) M) and carbachol (10(-9)-10(-5) M) in tracheal smooth muscle cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
956

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J., Grandordy B. M., Page C. P., Rhoden K. J., Robertson D. N. The effect of platelet activating factor on pulmonary beta-adrenoceptors. Br J Pharmacol. 1987 Apr;90(4):709–715. doi: 10.1111/j.1476-5381.1987.tb11224.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Benveniste J., Henson P. M., Cochrane C. G. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med. 1972 Dec 1;136(6):1356–1377. doi: 10.1084/jem.136.6.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bethel R. A., Curtis S. P., Lien D. C., Irvin C. G., Worthen G. S., Leff A. R., Henson P. M. Effect of PAF on parasympathetic contraction of canine airways. J Appl Physiol (1985) 1989 Jun;66(6):2629–2634. doi: 10.1152/jappl.1989.66.6.2629. [DOI] [PubMed] [Google Scholar]
  4. Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987 Jun;39(2):97–145. [PubMed] [Google Scholar]
  5. Christman B. W., Lefferts P. L., Snapper J. R. Effect of platelet-activating factor on aerosol histamine responsiveness in awake sheep. Am Rev Respir Dis. 1987 Jun;135(6):1267–1270. doi: 10.1164/arrd.1987.135.6.1267. [DOI] [PubMed] [Google Scholar]
  6. Chung K. F., Aizawa H., Leikauf G. D., Ueki I. F., Evans T. W., Nadel J. A. Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. J Pharmacol Exp Ther. 1986 Mar;236(3):580–584. [PubMed] [Google Scholar]
  7. Cumming G. Airway morphology and its consequences. Bull Physiopathol Respir (Nancy) 1972 May-Jun;8(3):527–533. [PubMed] [Google Scholar]
  8. Hakoda H., Ito Y. Modulation of cholinergic neurotransmission by the peptide VIP, VIP antiserum and VIP antagonists in dog and cat trachea. J Physiol. 1990 Sep;428:133–154. doi: 10.1113/jphysiol.1990.sp018204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hamasaki Y., Mojarad M., Saga T., Tai H. H., Said S. I. Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution. Am Rev Respir Dis. 1984 May;129(5):742–746. doi: 10.1164/arrd.1984.129.5.742. [DOI] [PubMed] [Google Scholar]
  10. Inoue T., Ito Y. Characteristics of neuro-effector transmission in the smooth muscle layer of dog bronchiole and modifications by autacoids. J Physiol. 1986 Jan;370:551–565. doi: 10.1113/jphysiol.1986.sp015950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ito Y., Inoue T. Contracture and change in membrane potential produced by sodium removal in the dog trachea and bronchiole. J Appl Physiol (1985) 1989 Nov;67(5):2078–2086. doi: 10.1152/jappl.1989.67.5.2078. [DOI] [PubMed] [Google Scholar]
  12. Ito Y., Tajima K. Actions of indomethacin and prostaglandins on neuro-effector transmission in the dog trachea. J Physiol. 1981;319:379–392. doi: 10.1113/jphysiol.1981.sp013915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ito Y., Yoshitomi T. Autoregulation of acetylcholine release from vagus nerve terminals through activation of muscarinic receptors in the dog trachea. Br J Pharmacol. 1988 Mar;93(3):636–646. doi: 10.1111/j.1476-5381.1988.tb10321.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jancar S., Thériault P., Braquet P., Sirois P. Comparative effects of platelet activating factor, leukotriene D4 and histamine on guinea pig trachea, bronchus and lung parenchyma. Prostaglandins. 1987 Feb;33(2):199–208. doi: 10.1016/0090-6980(87)90006-2. [DOI] [PubMed] [Google Scholar]
  15. Jancar S., Thériault P., Lauzière M., Braquet P., Sirois P. Paf-induced release of spasmogens from guinea-pig lungs. Br J Pharmacol. 1989 Jan;96(1):153–162. doi: 10.1111/j.1476-5381.1989.tb11795.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Leff A. R., White S. R., Munoz N. M., Popovich K. J., Shioya T., Stimler-Gerard N. P. Parasympathetic involvement in PAF-induced contraction in canine trachealis in vivo. J Appl Physiol (1985) 1987 Feb;62(2):599–605. doi: 10.1152/jappl.1987.62.2.599. [DOI] [PubMed] [Google Scholar]
  17. Lefort J., Rotilio D., Vargaftig B. B. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene. Br J Pharmacol. 1984 Jul;82(3):565–575. doi: 10.1111/j.1476-5381.1984.tb10795.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. O'Flaherty J. T., Wykle R. L. Biology and biochemistry of platelet-activating factor. Clin Rev Allergy. 1983 Sep;1(3):353–367. doi: 10.1007/BF02991226. [DOI] [PubMed] [Google Scholar]
  19. Popovich K. J., Sheldon G., Mack M., Munoz N. M., Denberg P., Blake J., White S. R., Leff A. R. Role of platelets in contraction of canine tracheal muscle elicited by PAF in vitro. J Appl Physiol (1985) 1988 Aug;65(2):914–920. doi: 10.1152/jappl.1988.65.2.914. [DOI] [PubMed] [Google Scholar]
  20. Robertson D. N., Coyle A. J., Rhoden K. J., Grandordy B., Page C. P., Barnes P. J. The effect of platelet-activating factor on histamine and muscarinic receptor function in guinea pig airways. Am Rev Respir Dis. 1988 Jun;137(6):1317–1322. doi: 10.1164/ajrccm/137.6.1317. [DOI] [PubMed] [Google Scholar]
  21. Robertson D. N., Page C. P. Effect of platelet agonists on airway reactivity and intrathoracic platelet accumulation. Br J Pharmacol. 1987 Sep;92(1):105–111. doi: 10.1111/j.1476-5381.1987.tb11301.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sakuma Y., Tsunoda H., Shirato M., Katayama S., Yamatsu I., Katayama K. Pharmacological effects of oral E6123, a novel PAF antagonist, on biological changes induced by PAF inhalation in guinea pigs. Prostaglandins. 1991 Nov;42(5):463–472. doi: 10.1016/0090-6980(91)90037-g. [DOI] [PubMed] [Google Scholar]
  23. Smith L. J., Rubin A. H., Patterson R. Mechanism of platelet activating factor-induced bronchoconstriction in humans. Am Rev Respir Dis. 1988 May;137(5):1015–1019. doi: 10.1164/ajrccm/137.5.1015. [DOI] [PubMed] [Google Scholar]
  24. Snyder F. Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether-linked choline-phospholipids. Med Res Rev. 1985 Jan-Mar;5(1):107–140. doi: 10.1002/med.2610050105. [DOI] [PubMed] [Google Scholar]
  25. Taylor I. K., Ward P. S., Taylor G. W., Dollery C. T., Fuller R. W. Inhaled PAF stimulates leukotriene and thromboxane A2 production in humans. J Appl Physiol (1985) 1991 Oct;71(4):1396–1402. doi: 10.1152/jappl.1991.71.4.1396. [DOI] [PubMed] [Google Scholar]
  26. Townley R. G., Hopp R. J., Agrawal D. K., Bewtra A. K. Platelet-activating factor and airway reactivity. J Allergy Clin Immunol. 1989 Jun;83(6):997–1010. doi: 10.1016/0091-6749(89)90437-5. [DOI] [PubMed] [Google Scholar]
  27. Tsunoda H., Sakuma Y., Harada K., Muramoto K., Katayama S., Horie T., Shimomura N., Clark R., Miyazawa S., Okano K. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Arzneimittelforschung. 1990 Nov;40(11):1201–1205. [PubMed] [Google Scholar]
  28. Vargaftig B. B., Chignard M., Benveniste J., Lefort J., Wal F. Background and present status of research on platelet-activating factor (PAF-acether). Ann N Y Acad Sci. 1981;370:119–137. doi: 10.1111/j.1749-6632.1981.tb29727.x. [DOI] [PubMed] [Google Scholar]
  29. Vargaftig B. B., Lefort J., Wal F., Chignard M. Role of the metabolites of arachidonate in platelet-dependent and independent experimental bronchoconstriction. Bull Eur Physiopathol Respir. 1981;17(4):723–736. [PubMed] [Google Scholar]
  30. Voelkel N. F., Worthen S., Reeves J. T., Henson P. M., Murphy R. C. Nonimmunological production of leukotrienes induced by platelet-activating factor. Science. 1982 Oct 15;218(4569):286–289. doi: 10.1126/science.7123233. [DOI] [PubMed] [Google Scholar]
  31. Xie Z., Hakoda H., Ito Y. Airway epithelial cells regulate membrane potential, neurotransmission and muscle tone of the dog airway smooth muscle. J Physiol. 1992 Apr;449:619–639. doi: 10.1113/jphysiol.1992.sp019105. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES